Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-23

FDA Approved: ATAZANAVIR SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Atazanavir sulfate submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atazanavir sulfate (atazanavir)

Snippet

SUPPL AP for ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)